6.3 Clinical Symptoms That Should Prompt Assessment Patients on GLP-1 therapy should seek review if experiencing: Persistent fatigue Hair thinning beyond expected telogen shift Neurological symptoms (numbness, tingling) Muscle weakness Persistent vomiting Severe dietary restriction These symptoms are non-specific but warrant nutritional evaluation
Additionally, these drugs can protect -cells from apoptosis and may stimulate their regeneration
Retatrutide belongs to a new class of drugs called triple agonists
While the primary mechanism is still under investigation, the systemic impact of GLP-1 receptor agonists on sebum production and inflammation is a key area of study for experts like Dr
Since the re-release of Wegovy in 2021, both have rapidly become the talk of the digital town, turning the wheel of a virtuous cycle that has propelled them into the global spotlight
But Eli Lilly accused Novo of asking the court to stop the company from communicating the results of a comparison trial it said was "robustly designed" and "the gold standard".